| Disorder | Symbol(s) | OMIM | Location |
| Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency (3) | CYP21A2, CYP21, CA21H | 201910 |
6p21.3 |
| Adrenal hyperplasia, congenital, due to combined P450C17 and P450C21 deficiency, 201750 (3) | POR | 124015 |
7q11.2 |
| Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism, 300200 (3) | DAX1, AHC, AHX, NROB1 | 300473 |
Xp21.3-p21.2 |
| Adrenal insufficiency, congenital with or without 46, XY sex reversal (3) | CYP11A, P450SCC | 118485 |
15q23-q24 |
| Adrenocortical insufficiency (3) | NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7 | 184757 |
9q33 |
| Adrenocortical tumor, somatic (3) | PRKAR1A, TSE1, CNC1, CAR, PPNAD1 | 188830 |
17q23-q24 |
| Adrenocorticotropic hormone deficiency, 201400 (3) | TBS19 | 604614 |
1q23-q24 |
| Adrenoleukodystrophy, 300100 (3) | ABCD1, ALD, AMN | 300371 |
Xq28 |
| Adrenoleukodystrophy, neonatal, 202370 (3) | PEX1, ZWS1 | 602136 |
7q21-q22 |
| Adrenoleukodystrophy, neonatal, 202370 (3) | PEX10, NALD | 602859 |
1p36.32 |
| Adrenoleukodystrophy, neonatal, 202370 (3) | PEX13, ZWS, NALD | 601789 |
2p15 |
| Adrenoleukodystrophy, neonatal, 202370 (3) | PEX26 | 608666 |
22q11.21 |
| Adrenoleukodystrophy, neonatal, 202370 (3) | PEX5, PXR1, PTS1R | 600414 |
12p13.3 |
| Adrenomyeloneuropathy, 300100 (3) | ABCD1, ALD, AMN | 300371 |
Xq28 |
| Adult i phenotype with congenital cataract, 110800 (3) | GCNT2 | 600429 |
6p24-p23 |
| Adult i phenotype without cataract, 110800 (3) | GCNT2 | 600429 |
6p24-p23 |
| Advanced sleep phase syndrome, familial, 604348 (3) | PER2, FASPS, KIAA0347 | 603426 |
2q37.3 |
| Afibrinogenemia, congenital, 202400 (3) | FGA | 134820 |
4q28 |
| Afibrinogenemia, congenital, 202400 (3) | FGB | 134830 |
4q28 |
| Agammaglobulinemia and isolated hormone deficiency, 307200 (3) | BTK, AGMX1, IMD1, XLA, AT | 300300 |
Xq21.3-q22 |
